The Ryan White program handles payment for a substantial portion of US HIV patients, so this deal will help ABBV/ENTA in the co-infected portion of the HCV market.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.